查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1618595

醫療事務外包市場：按服務、業務模式和最終用戶分類 - 全球預測 2025-2030

Medical Affairs Outsourcing Market by Services, Operational Model, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年醫療事務外包市場規模為97.8億美元，預計2024年將達到111.6億美元，複合年成長率為14.59%，預計到2030年將達到253.9億美元。

醫療事務外包涉及與第三方供應商簽訂契約，管理製藥、生物技術和醫療設備公司醫療事務部門內的各種職能。外包的關鍵服務包括醫學寫作、監管提交、醫療資訊和策略諮詢，以確保遵守不斷變化的法規。外包的需求源自於最佳化業務效率、專注於核心競爭力、降低成本和解決資源稀缺挑戰的需要，尤其是中小型企業。其應用範圍從臨床試驗資料管理到行銷、藥物安全和醫學教育，最終支援產品發布和生命週期管理。創新正在推動成長，特別是在製藥和生物技術領域，需要專業知識的複雜治療領域不斷增加。

主要市場統計
基準年[2023] 97.8億美元
預計年份 [2024] 111.6億美元
預測年份 [2030] 253.9億美元
複合年成長率（%） 14.59%

影響成長的關鍵因素包括研發費用增加、對特殊藥物的關注增加以及對合規和監管管理的需求增加。現代商業機會由人工智慧和機器學習等技術進步提供動力，這些技術進步可以改善資料管理、分析和決策流程。企業可以透過投資技術主導的解決方案並與創新的外包服務提供者建立夥伴關係來利用這些優勢。然而，資料隱私問題、品管問題以及維持第三方和內部團隊之間有凝聚力的溝通管道等挑戰構成了重大障礙。監管環境也在不斷發展，增加了維持合規性的複雜性。

創新機會在於使用需要嚴格醫療事務投入的數位健康工具和個人化醫療方法。專注於整合人工智慧進行即時資料分析和預測洞察的研究領域將提供長期價值。由於市場的特點是技術快速採用和激烈競爭，公司應致力於策略性投資於敏捷且可擴展的解決方案。專注於合規性、利用策略聯盟並增強服務產品以有效滿足不斷變化的客戶需求是成功的關鍵。

市場動態：揭示快速發展的醫療事務外包市場的關鍵市場洞察

醫療事務外包市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 擴大藥物管道並增加臨床資料的複雜性
    • 醫學出版品和教育內容的增加
    • 對實證醫學和價值醫療保健的需求不斷成長
  • 市場限制因素
    • 與委託職能的溝通和品質相關的限制
  • 市場機會
    • 將人工智慧和機器學習技術融入醫療事務外包
    • 製藥公司與外包公司的策略合作
  • 市場挑戰
    • 對機密性和資料安全風險的擔憂

波特五力：駕馭醫療事務外包市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解醫療事務外包市場的外部影響

外部宏觀環境因素在塑造醫療事務外包市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解醫療事務外包市場的競爭狀況

醫療事務外包市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 醫療事務外包市場定位矩陣供應商績效評估

FPNV 定位矩陣是評估醫療事務外包市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製醫療事務外包市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對醫療事務外包市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告提供了涵蓋關鍵重點領域的市場全面分析：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 擴大藥物管道並增加臨床資料的複雜性
      • 醫學出版品和教育內容的增加
      • 對實證醫學和價值醫療保健的需求不斷成長
    • 抑制因素
      • 與外包職能的溝通和品質相關的限制
    • 機會
      • 將人工智慧和機器學習技術融入醫療事務外包
      • 製藥公司與外包公司的策略合作
    • 任務
      • 對機密性和資料安全風險的擔憂
  • 市場區隔分析
    • 服務：更多採用醫療業務外包，為複雜的監管路徑提供策略指導
    • 營運模式：採用功能性服務模式來獲得醫學寫作和資料分析關鍵領域的有針對性的專業知識
    • 最終用戶：透過最終用戶的多樣化應用程式簡化營運成本
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 醫療事務外包市場：依服務分類

  • 醫療通訊
  • 醫療資訊服務
  • 醫療監測
  • 醫藥學術專員
  • 醫學寫作和出版

第7章依營運模式分類的醫療事務外包市場

  • 全程服務外包
  • 功能外包
  • 部分/任務式的外包

第8章 醫療事務外包市場：依最終使用者分類

  • 生物技術和製藥公司
  • 合約調查機構
  • 醫院
  • 醫療設備公司
  • 療養院

第9章 美洲醫療事務外包市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太醫療事務外包市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東、非洲醫療事務外包市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 全球醫療技術 CRO NAMSA 宣布與Terumo Corporation Aorta 建立策略外包夥伴關係
    • Millstone 醫療外包完成無塵室設施擴建
    • 工業和百時美施貴寶與 PRiME-R 簽署委託，在日本利用網路腫瘤學對Opdivo進行胃癌患者的臨床研究
  • 戰略分析和建議

公司名單

  • Accenture PLC
  • Ashfield Healthcare Communications by Inizio
  • Biomapas Group
  • Charles River Laboratories International, Inc.
  • Comprehend Systems, Inc. by Saama Technologies, Inc.
  • Excelya
  • Freyr Solutions
  • Genpact
  • Groupe ProductLife SA
  • ICON PLC
  • Indegene, Inc.
  • Insuvia
  • IQVIA Holdings, Inc.
  • JSS Medical Research Inc
  • Medpace Holdings, Inc.
  • MMS Holdings Inc.
  • PAREXEL International Corporation
  • Pharmalex by BlueReg
  • PPD, Inc. by Thermo Fischer Scientific Inc.
  • ProPharma Group
  • SGS SA
  • Syneos Health, Inc.
  • The Medical Affairs Company
  • Wuxi Clinical Development, Inc.
  • Zeincro Group
Product Code: MRR-433C4187C541

The Medical Affairs Outsourcing Market was valued at USD 9.78 billion in 2023, expected to reach USD 11.16 billion in 2024, and is projected to grow at a CAGR of 14.59%, to USD 25.39 billion by 2030.

Medical Affairs Outsourcing involves contracting third-party vendors to manage various functions within the medical affairs segments of pharmaceutical, biotechnology, and medical device companies. Core services often outsourced include medical writing, regulatory submissions, medical information, and strategic consultancy, ensuring compliance with ever-changing regulations. The necessity for outsourcing arises from the need to optimize operational efficiencies, focus on core competencies, reduce costs, and address resource deficit challenges, especially in small to mid-sized companies. Applications range from managing clinical trial data to marketing, drug safety, and medical education, ultimately supporting the launch and lifecycle management of products. The end-use scope is extensive, especially within pharmaceutical and biotech sectors, where innovation drives growth, alongside an increase in complex therapy areas that demand specialized knowledge.

KEY MARKET STATISTICS
Base Year [2023] USD 9.78 billion
Estimated Year [2024] USD 11.16 billion
Forecast Year [2030] USD 25.39 billion
CAGR (%) 14.59%

Key factors influencing growth include rising R&D expenditures, increased emphasis on specialty drugs, and heightened demand for compliance and regulatory affairs management. The latest opportunities are underpinned by technological advancements like AI and machine learning that improve data management, analytics, and decision-making processes. Companies can capitalize on these by investing in technology-driven solutions and fostering partnerships with innovative outsourcing service providers. However, challenges such as data privacy concerns, quality control issues, and maintaining cohesive communication channels between third parties and in-house teams pose significant barriers. The regulatory landscape is also continually evolving, adding complexity to maintaining compliance.

Innovation opportunities lie in the use of digital health tools and personalized medicine approaches that demand rigorous medical affairs input. Research areas focusing on the integration of AI for real-time data analysis and predictive insights offer long-term value. As the market is characterized by rapid technological adoption and substantial competition, companies must aim for agility and strategic investments in scalable solutions. Successful navigation will rely on maintaining a clear focus on compliance, leveraging strategic collaborations, and enhancing service offerings to address evolving client needs efficiently.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Medical Affairs Outsourcing Market

The Medical Affairs Outsourcing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Expansion of pharmaceutical pipeline and growing complexity of clinical data
    • Increase in the volume of medical publications and educational content
    • Rising demand for evidence-based medicine and value-based healthcare
  • Market Restraints
    • Limitations associated with communication and quality of outsourced functions
  • Market Opportunities
    • Inclusion of AI & ML technologies in medical affairs outsourcing
    • Strategic collaborations between pharmaceutical companies and outsourcing firms
  • Market Challenges
    • Concerns associated with confidentiality and data security risks

Porter's Five Forces: A Strategic Tool for Navigating the Medical Affairs Outsourcing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Medical Affairs Outsourcing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Medical Affairs Outsourcing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Medical Affairs Outsourcing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Medical Affairs Outsourcing Market

A detailed market share analysis in the Medical Affairs Outsourcing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Medical Affairs Outsourcing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Medical Affairs Outsourcing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Medical Affairs Outsourcing Market

A strategic analysis of the Medical Affairs Outsourcing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Medical Affairs Outsourcing Market, highlighting leading vendors and their innovative profiles. These include Accenture PLC, Ashfield Healthcare Communications by Inizio, Biomapas Group, Charles River Laboratories International, Inc., Comprehend Systems, Inc. by Saama Technologies, Inc., Excelya, Freyr Solutions, Genpact, Groupe ProductLife S.A., ICON PLC, Indegene, Inc., Insuvia, IQVIA Holdings, Inc., JSS Medical Research Inc, Medpace Holdings, Inc., MMS Holdings Inc., PAREXEL International Corporation, Pharmalex by BlueReg, PPD, Inc. by Thermo Fischer Scientific Inc., ProPharma Group, SGS S.A., Syneos Health, Inc., The Medical Affairs Company, Wuxi Clinical Development, Inc., and Zeincro Group.

Market Segmentation & Coverage

This research report categorizes the Medical Affairs Outsourcing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Services, market is studied across Medical Communications, Medical Information Services, Medical Monitoring, Medical Science Liaisons, and Medical Writing & Publishing.
  • Based on Operational Model, market is studied across Full-Service Outsourcing, Functional Outsourcing, and Partial/Task-based Outsourcing.
  • Based on End-User, market is studied across Biotechnology & Pharmaceutical Companies, Contract Research Organization, Hospitals, Medical Device Companies, and Nursing Homes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Expansion of pharmaceutical pipeline and growing complexity of clinical data
      • 5.1.1.2. Increase in the volume of medical publications and educational content
      • 5.1.1.3. Rising demand for evidence-based medicine and value-based healthcare
    • 5.1.2. Restraints
      • 5.1.2.1. Limitations associated with communication and quality of outsourced functions
    • 5.1.3. Opportunities
      • 5.1.3.1. Inclusion of AI & ML technologies in medical affairs outsourcing
      • 5.1.3.2. Strategic collaborations between pharmaceutical companies and outsourcing firms
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with confidentiality and data security risks
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Services: Rising adoption of medical affair outsourcing for strategic guidance to navigate the intricate regulatory pathways
    • 5.2.2. Operational Model: Adoption of functional service model to attain targeted expertise in vital areas of medical writing and data analysis
    • 5.2.3. End User: Diverse applications across end-users for operational cost efficiency
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Medical Affairs Outsourcing Market, by Services

  • 6.1. Introduction
  • 6.2. Medical Communications
  • 6.3. Medical Information Services
  • 6.4. Medical Monitoring
  • 6.5. Medical Science Liaisons
  • 6.6. Medical Writing & Publishing

7. Medical Affairs Outsourcing Market, by Operational Model

  • 7.1. Introduction
  • 7.2. Full-Service Outsourcing
  • 7.3. Functional Outsourcing
  • 7.4. Partial/Task-based Outsourcing

8. Medical Affairs Outsourcing Market, by End-User

  • 8.1. Introduction
  • 8.2. Biotechnology & Pharmaceutical Companies
  • 8.3. Contract Research Organization
  • 8.4. Hospitals
  • 8.5. Medical Device Companies
  • 8.6. Nursing Homes

9. Americas Medical Affairs Outsourcing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Medical Affairs Outsourcing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Medical Affairs Outsourcing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Global MedTech CRO, NAMSA, Announces Strategic Outsourcing Partnership With Terumo Aortic
    • 12.3.2. Millstone Medical Outsourcing Completes Clean Room Facility Expansion
    • 12.3.3. ONO and Bristol Myers Squibb Sign Outsourcing Agreement with PRiME-R on Clinical Research of Opdivo in Patients with Gastric Cancer, utilizing CyberOncology in Japan
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accenture PLC
  • 2. Ashfield Healthcare Communications by Inizio
  • 3. Biomapas Group
  • 4. Charles River Laboratories International, Inc.
  • 5. Comprehend Systems, Inc. by Saama Technologies, Inc.
  • 6. Excelya
  • 7. Freyr Solutions
  • 8. Genpact
  • 9. Groupe ProductLife S.A.
  • 10. ICON PLC
  • 11. Indegene, Inc.
  • 12. Insuvia
  • 13. IQVIA Holdings, Inc.
  • 14. JSS Medical Research Inc
  • 15. Medpace Holdings, Inc.
  • 16. MMS Holdings Inc.
  • 17. PAREXEL International Corporation
  • 18. Pharmalex by BlueReg
  • 19. PPD, Inc. by Thermo Fischer Scientific Inc.
  • 20. ProPharma Group
  • 21. SGS S.A.
  • 22. Syneos Health, Inc.
  • 23. The Medical Affairs Company
  • 24. Wuxi Clinical Development, Inc.
  • 25. Zeincro Group

LIST OF FIGURES

  • FIGURE 1. MEDICAL AFFAIRS OUTSOURCING MARKET RESEARCH PROCESS
  • FIGURE 2. MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. MEDICAL AFFAIRS OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. MEDICAL AFFAIRS OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MEDICAL AFFAIRS OUTSOURCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MEDICAL AFFAIRS OUTSOURCING MARKET DYNAMICS
  • TABLE 7. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL INFORMATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL SCIENCE LIAISONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING & PUBLISHING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY FULL-SERVICE OUTSOURCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY FUNCTIONAL OUTSOURCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PARTIAL/TASK-BASED OUTSOURCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NURSING HOMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. MEDICAL AFFAIRS OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 151. MEDICAL AFFAIRS OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023